Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis

Ioannis D Gallos; Jason Yap; Madhurima Rajkhowa; David M Luesley; Aravinthan Coomarasamy; Janesh K Gupta

doi:10.1016/j.ajog.2012.08.011

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis

Ioannis D Gallos, Jason Yap, Madhurima Rajkhowa, David M Luesley, Aravinthan Coomarasamy, Janesh K Gupta

Research output: Contribution to journal › Article › peer-review

168 Citations (Scopus)

Abstract

The objective of the study was to evaluate the regression, relapse, and live birth rates of early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH) with fertility-sparing treatment.

Original language	English
Pages (from-to)	266.e1-12
Journal	American journal of obstetrics and gynecology
Volume	207
Issue number	4
DOIs	https://doi.org/10.1016/j.ajog.2012.08.011
Publication status	Published - Oct 2012

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ajog.2012.08.011

Cite this

Gallos, I. D., Yap, J., Rajkhowa, M., Luesley, D. M., Coomarasamy, A., & Gupta, J. K. (2012). Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. American journal of obstetrics and gynecology, 207(4), 266.e1-12. https://doi.org/10.1016/j.ajog.2012.08.011

@article{1bedd609f9664fa19b90c0d2cde21bed,

title = "Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis",

abstract = "The objective of the study was to evaluate the regression, relapse, and live birth rates of early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH) with fertility-sparing treatment.",

author = "Gallos, {Ioannis D} and Jason Yap and Madhurima Rajkhowa and Luesley, {David M} and Aravinthan Coomarasamy and Gupta, {Janesh K}",

year = "2012",

month = oct,

doi = "10.1016/j.ajog.2012.08.011",

language = "English",

volume = "207",

pages = "266.e1--12",

journal = "American journal of obstetrics and gynecology",

issn = "1097-6868",

publisher = "Elsevier",

number = "4",

}

Gallos, ID , Yap, J, Rajkhowa, M, Luesley, DM, Coomarasamy, A & Gupta, JK 2012, 'Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis', American journal of obstetrics and gynecology, vol. 207, no. 4, pp. 266.e1-12. https://doi.org/10.1016/j.ajog.2012.08.011

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. / Gallos, Ioannis D ; Yap, Jason; Rajkhowa, Madhurima et al.
In: American journal of obstetrics and gynecology, Vol. 207, No. 4, 10.2012, p. 266.e1-12.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia

T2 - a systematic review and metaanalysis

AU - Gallos, Ioannis D

AU - Yap, Jason

AU - Rajkhowa, Madhurima

AU - Luesley, David M

AU - Coomarasamy, Aravinthan

AU - Gupta, Janesh K

PY - 2012/10

Y1 - 2012/10

N2 - The objective of the study was to evaluate the regression, relapse, and live birth rates of early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH) with fertility-sparing treatment.

AB - The objective of the study was to evaluate the regression, relapse, and live birth rates of early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH) with fertility-sparing treatment.

U2 - 10.1016/j.ajog.2012.08.011

DO - 10.1016/j.ajog.2012.08.011

M3 - Article

C2 - 23021687

SN - 1097-6868

VL - 207

SP - 266.e1-12

JO - American journal of obstetrics and gynecology

JF - American journal of obstetrics and gynecology

IS - 4

ER -

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Cite this